Monthly Archives: November 2018
Sam Knight, a staff writer at The New Yorker wrote a wonderful piece on the rise of palaeoproteomics, and as a side effect he helped to advance the mainstream understanding on what high-throughput mass spec proteomics (AgeCurve’s main method) can deliver.
Earlier this November I was giving a talk at the Fourth Eurosymposium on Healthy Ageing in Brussels. It was a great, like-minded audience with plenty good questions and suggestions. Let me thank here the organisers, Didier Coeurnelle and Sven Bulterijs for giving me this opportunity. Please see abstract of the talk: Proteins are the main action […]
NHS prevention plan for explicitly longer and healthier lives: a historical first longevity initiative?
A BBC piece called NHS prevention plan aims to boost life expectancy tells us about a prevention plan that might be a historical first longevity initiative at such a governmental scale: In his speech later, Mr Hancock is expected to set out his aim for people to have five more years of healthy, independent life by […]
AgeCurve’s founder and director, Attila Csordas has been invited to give a talk and participate in a panel discussion at the inaugural Longevity World Forum on the 8th of November in Valencia, Spain. The talk is entitled ‘AgeCurve, proteomics and extending healthspan: from free solo to aided rock climbing’.